MicroSteer
Endoscopic Add-on Device for the Removal of Complex Lesions
Company Overview
Snapshot
Founded in January 2023 by Ofer Pillar and Adi Strauss, MicroSteer operates with 1–10 employees. The company has secured Pre-Seed funding from NGT HealthCare II. MicroSteer is developing a robotic system for endoscopic removal of complex GI tumors, aiming to avoid open or laparoscopic surgeries.
Business overview
MicroSteer is a Health Tech & Life Sciences company developing an innovative robotic system designed to enhance the endoscopic removal of complex gastrointestinal tumors. Its core product is a steered polypectomy device, Phalcon-1, which functions as an endoscopic add-on. This technology aims to provide endoscopists with a safer and faster procedure, traditionally performed by highly experienced interventional gastroenterologists or surgeons, thereby expanding access to less invasive treatment options. The company operates within the medical devices sector, specifically focusing on medical treatment and therapeutics, and serves the healthcare industry, targeting providers.
Log in to access full profile ›Company Intelligence Q&A
- When was MicroSteer founded?
- MicroSteer was founded in January 2023.
- Who are the founders of MicroSteer?
- MicroSteer was founded by Ofer Pillar and Adi Strauss.
- What is MicroSteer's primary product?
- MicroSteer is developing Phalcon-1, a steered polypectomy device designed as an endoscopic add-on for the removal of complex GI tumors.
- Which investor participated in MicroSteer's funding round?
- In January 2023, MicroSteer secured Pre-Seed funding from NGT HealthCare II.
- What problem does MicroSteer's technology aim to solve?
- MicroSteer's technology aims to enable the endoscopic removal of complex GI tumors, offering a less invasive alternative to open or laparoscopic surgeries and making the procedure safer and faster for endoscopists.